There are approximately 8000 different rare diseases, affecting 6% or about 350 million people in the world. The quality of life of patients and families with rare diseases is often compromised by the lack of a correct molecular diagnosis, leading to risk of wrong diagnosis and inaccurate treatments. To ensure access to appropriate treatments and quality personalized health care, more information about the whole life perspective of the disease is needed.
Menu for this area
Research group leaders
Ann Nordgren is a group leader for the rare diseases group
Anna Lindstrand is a group leader for the rare diseases group